| Title |
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery
|
|---|---|
| Published in |
Clinical Drug Investigation, July 2019
|
| DOI | 10.1007/s40261-019-00830-4 |
| Pubmed ID | |
| Authors |
M. Soledad Cepeda, David M. Kern, Guy R. Seabrook, Simon Lovestone |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 25% |
| United States | 2 | 25% |
| Japan | 1 | 13% |
| Unknown | 3 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 88% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 31 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 6 | 19% |
| Researcher | 4 | 13% |
| Student > Master | 3 | 10% |
| Student > Ph. D. Student | 1 | 3% |
| Student > Doctoral Student | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 15 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 19% |
| Philosophy | 1 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Business, Management and Accounting | 1 | 3% |
| Agricultural and Biological Sciences | 1 | 3% |
| Other | 6 | 19% |
| Unknown | 15 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2022.
All research outputs
#6,737,973
of 22,818,766 outputs
Outputs from Clinical Drug Investigation
#240
of 962 outputs
Outputs of similar age
#119,855
of 344,817 outputs
Outputs of similar age from Clinical Drug Investigation
#4
of 14 outputs
Altmetric has tracked 22,818,766 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 962 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,817 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.